Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
CONCLUSION: Data from both randomized and non-randomized studies suggest that AdoMet improves some biochemical liver parameters and symptoms of cholestasis within 2 wk, with further improvements observed in some studies after 4 and 8 wk of treatment.
PMID: 32184941 [PubMed]
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research
More News: Cholestasis | Depression | Gastroenterology | Liver | Liver Disease | Magnesium | Obstetric Cholestasis | Potassium | Study | Urology & Nephrology